Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vera Therapeutics Inc.

    NASDAQ: VERA · Real-Time Price · USD
    21.61
    -0.24 (-1.10%)
    At close: Jun 17, 2025, 10:20 AM

    Vera Therapeutics Statistics

    Share Statistics

    Vera Therapeutics has 63.77M shares outstanding. The number of shares has increased by 16.54% in one year.

    Shares Outstanding

    n/a
    		 63.77M

    Shares Change (YoY)

    n/a
    		 16.54%

    Shares Change (QoQ)

    n/a
    		 0.67%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 48.07M

    Failed to Deliver (FTD) Shares

    n/a
    		 87

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 8.95M, so 14.03% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.95M

    Short % of Shares Out

    n/a
    		 14.03%

    Short % of Float

    n/a
    		 16.17%

    Short Ratio (days to cover)

    n/a
    		 7.89

    Valuation Ratios

    The PE ratio is -15.38 and the forward PE ratio is -6.59. Vera Therapeutics's PEG ratio is -0.69.

    PE Ratio

    n/a
    		 -15.38

    Forward PE

    n/a
    		 -6.59

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.6

    PB Ratio

    n/a
    		 4.05

    P/FCF Ratio

    n/a
    		 -17.25

    PEG Ratio

    n/a
    		 -0.69
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Vera Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 25.67, with a Debt / Equity ratio of 0.09.

    Current Ratio

    n/a
    		 25.67

    Quick Ratio

    n/a
    		 25.67

    Debt / Equity

    n/a
    		 0.09

    Debt / EBITDA

    n/a
    		 -0.33

    Debt / FCF

    n/a
    		 -0.4

    Interest Coverage

    n/a
    		 -21.92

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,000,973.68

    Employee Count

    n/a
    		 152

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 1K

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -38.83% in the last 52 weeks. The beta is 1.13, so Vera Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.13

    52-Week Price Change

    n/a
    		 -38.83%

    50-Day Moving Average

    n/a
    		 22.52

    200-Day Moving Average

    n/a
    		 34.4

    Relative Strength Index (RSI)

    n/a
    		 46.1

    Average Volume (20 Days)

    n/a
    		 1,667,496

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -167.17M

    Net Income

    n/a
    		 -152.15M

    EBITDA

    n/a
    		 -167.17M

    EBIT

    n/a
    		 -159.77M

    Earnings Per Share (EPS)

    n/a
    		 -2.75
    Full Income Statement

    Balance Sheet

    The company has 92.65M in cash and 54.64M in debt, giving a net cash position of 38.01M.

    Cash & Cash Equivalents

    n/a
    		 92.65M

    Total Debt

    n/a
    		 54.64M

    Net Cash

    n/a
    		 38.01M

    Retained Earnings

    n/a
    		 -461.25M

    Total Assets

    n/a
    		 610.17M

    Working Capital

    n/a
    		 584.18M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -134.68M and capital expenditures -972K, giving a free cash flow of -135.65M.

    Operating Cash Flow

    n/a
    		 -134.68M

    Capital Expenditures

    n/a
    		 -972K

    Free Cash Flow

    n/a
    		 -135.65M

    FCF Per Share

    n/a
    		 -2.45
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    VERA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for VERA is $65.5, which is 199.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $65.5

    Price Target Difference

    n/a
    		 199.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 9.16

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist